Consequently, previous studies have revealed that distinct alterations of the hypothalamic–pituitary–adrenal (HPA) axis activity [9], inflammatory characteristics [10], gut microbiota abundance [11], and metabolism of brain-derived neurotrophic factor (BDNF) [12] may play a critical role for MDD patients with and without anhedonia. This evidence concerns the gene BDNF and major depressive disorder.